Home|Journals|Articles by Year|Audio Abstracts

Original Article

ECB. 2021; 10(3): 134-138


A. Guèye, Papa Sambra Camara, F. Faye, A. Gaye, F. Tamboura, N. Gruber, M. Gaye.


Asymmetrical ligand (Z)-N'-(phenyl(pyridin-2-yl)methylene)nicotinohydrazide (I) was synthesized from the condensation of nicotinic acid hydrazide with 2-benzoylpyridine. The compound was characterized by physicochemical analyses, elemental analysis, FTIR, 1H and 13C NMR spectroscopy techniques. The structure of the compound was determined by a single-crystal X-ray diffraction study. The ligand crystallizes in the triclinic space group P-1 with the following unit cell parameters: a = 8.2699 (11) Å, b = 8.6514 (8) Å, c = 11.583 (11) Å, a = 91.308 (3)°, b = 94.155 (5)°, g = 109.008 (4)°, V = 755.17 (14) Å3, Z = 2, R1 = 0.050, wR2 = 0.145. The carbonohydrazone moiety of the molecule is slightly twisted as reflected by the torsion angles values of -1.2 (2)° [O1—C13—N3—N2]. The dihedral angle between the mean planes of the pyridine rings is 11.799 (9)°. The crystal packing of compound (I) is stabilized by intramolecular N(carbohydrazide)–H···N(pyridine) and intermolecular C(phenyl)–H···O(amide) and C(phenyl)–H···N(hydrazino) hydrogen bonds, leading to the formation of sheets parallel to ac plane. The compound screened for antioxidant activity showed variable DPPH inhibition value for different concentrations of DPPH solution.

Key words: 2-benzoylpyridine; IR and NMR spectroscopy; Nicotinohydrazide; Single-crystal X-ray diffraction

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.